Overview

Efficacy of MND-2119 in Participants With Hypertriglyceridemia

Status:
Completed
Trial end date:
2019-06-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of MND-2119 compared to EPADEL CAPSULES 300 in participants with hypertriglyceridemia.
Phase:
Phase 3
Details
Lead Sponsor:
Mochida Pharmaceutical Company, Ltd.
Treatments:
Eicosapentaenoic acid ethyl ester